M. Delion

Bone demineralization is improved by ivacaftor in patients with cystic fibrosis carrying the p.Gly551Asp mutation.

I. Durieu, I. Sermet-Gaudelus, D. Hubert, 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

An Improved Inhaled Mucolytic to Treat Airway Muco‐obstructive Diseases

Boya Wang, S. Donaldson, D. Hill, 2019, American journal of respiratory and critical care medicine.

Cystic fibrosis and bone disease: defective osteoblast maturation with the F508del mutation in cystic fibrosis transmembrane conductance regulator.

L. Touqui, I. Sermet-Gaudelus, C. Guillaume, 2014, American journal of respiratory and critical care medicine.

Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies

S. Gangloff, F. Velard, J. Jacquot, 2016, Osteoporosis International.

Vardenafil increases intracellular accumulation of the most prevalent mutant cystic fibrosis transmembrane conductance regulator (CTFR) in human bronchial epithelial cells

A. Mottais, C. Bouzin, E. Hermans, 2020, Biology Open.

Overexpression of RANKL in osteoblasts: a possible mechanism of susceptibility to bone disease in cystic fibrosis

I. Sermet-Gaudelus, C. Guillaume, S. Gangloff, 2016, The Journal of pathology.

Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis

M. Wolfgang, S. Stick, D. Hill, 2019, Science Translational Medicine.

Cystic fibrosis bone disease: is the CFTR corrector C18 an option for therapy?

L. Touqui, F. Le Pimpec Barthès, I. Sermet-Gaudelus, 2014, European Respiratory Journal.

Treatment of cystic fibrosis airway cells with CFTR modulators reverses aberrant mucus properties via hydration

M. Drumm, M. Gentzsch, D. Hill, 2021, European Respiratory Journal.

Vardenafil increases intracellular accumulation of the most prevalent mutant CFTR in human bronchial epithelial cells.

A. Mottais, C. Bouzin, E. Hermans, 2020, Biology open.